This invention provides aryl and heteroaryl compounds of Formula (I) as described herein, and methods of their preparation. Also provided are pharmaceutical compositions made with the compounds of Formula (I) and methods for making such compositions. The compounds of Formula (I) may activate an erythropoietin receptor and thus, may be useful to induce red blood cell production. The compounds of Formula (I) and compositions including compounds of Formula (I) may be useful in a variety of applications including the management, treatment and/or control of diseases caused at least in part by deficient (or inefficient) EPO production relative to hemoglobin level.
这项发明提供了如下所述的Formula (I)的芳基和杂环芳基化合物,以及它们的制备方法。还提供了使用Formula (I)化合物制备的药物组合物,以及制备这种组合物的方法。Formula (I)的化合物可能激活促红细胞生成素受体,因此可能有助于诱导红细胞的产生。包括Formula (I)化合物的化合物和组合物可能在各种应用中有用,包括管理、治疗和/或控制至少部分由于相对于血红蛋白
水平缺乏(或效率低下)EPO产生而引起的疾病。